Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EBMT 2021 | CMWP activities in the field of CMML

Francesco Onida • 19 Mar 2021
EBMT 2021
Chronic Myelomonocytic Leukemia Leukemia Rare Diseases

Francesco Onida, MD, University of Milan, Milan, Italy, gives an overview of his work with the Chronic Malignancy Working Party (CMWP) and the Myelodysplastic Syndromes (MDS) Committee. Dr Onida, who is responsible for studies in patients with chronic myelomonocytic leukemia (CMML), describes challenges associated with treating CMML due to its heterogeneity and elderly demographic. This interview took place during the 47th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT) 2021.

More from Francesco Onida

Viral infections in patients undergoing SCT
6:50
Viral infections in patients undergoing SCT
Francesco Onida • 19 Mar 2021
Maintenance therapy after allogeneic HSCT in MDS
6:20
Maintenance therapy after allogeneic HSCT in MDS
Francesco Onida • 19 Mar 2021

Related Videos

Unmet needs in CLL genomics: heterogeneity and clinical impact
1:11
Unmet needs in CLL genomics: heterogeneity and clinical impact
Elias Campo • 16 Oct 2026
Insights into key topics most likely to impact day-to-day CLL management
1:40
Insights into key topics most likely to impact day-to-day CLL management
Alessandra Ferrajoli • 16 Oct 2026
Translating current CLL evidence into national guidelines: which gaps remain?
3:33
Translating current CLL evidence into national guidelines: which gaps remain?
Mary Ann Anderson • 16 Oct 2026
Frontline management of Richter’s transformation: current approaches and remaining uncertainties
2:40
Frontline management of Richter’s transformation: current approaches and remaining uncertainties
Philip Thompson • 22 Oct 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals